Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

26 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Pharmacokinetics of the combination tablet of buprenorphine and naloxone.
Chiang CN, Hawks RL. Chiang CN, et al. Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S39-47. doi: 10.1016/s0376-8716(03)00058-9. Drug Alcohol Depend. 2003. PMID: 12738349 Review.
Modafinil influences the pharmacokinetics of intravenous cocaine in healthy cocaine-dependent volunteers.
Donovan JL, DeVane CL, Malcolm RJ, Mojsiak J, Chiang CN, Elkashef A, Taylor RM. Donovan JL, et al. Clin Pharmacokinet. 2005;44(7):753-65. doi: 10.2165/00003088-200544070-00006. Clin Pharmacokinet. 2005. PMID: 15966757 Clinical Trial.
Pharmacokinetics and pharmacodynamics of multiple sublingual buprenorphine tablets in dose-escalation trials.
Ciraulo DA, Hitzemann RJ, Somoza E, Knapp CM, Rotrosen J, Sarid-Segal O, Ciraulo AM, Greenblatt DJ, Chiang CN. Ciraulo DA, et al. J Clin Pharmacol. 2006 Feb;46(2):179-92. doi: 10.1177/0091270005284192. J Clin Pharmacol. 2006. PMID: 16432270
Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone.
Fudala PJ, Bridge TP, Herbert S, Williford WO, Chiang CN, Jones K, Collins J, Raisch D, Casadonte P, Goldsmith RJ, Ling W, Malkerneker U, McNicholas L, Renner J, Stine S, Tusel D; Buprenorphine/Naloxone Collaborative Study Group. Fudala PJ, et al. N Engl J Med. 2003 Sep 4;349(10):949-58. doi: 10.1056/NEJMoa022164. N Engl J Med. 2003. PMID: 12954743 Clinical Trial.
Intravenous cocaine and QT variability.
Haigney MC, Alam S, Tebo S, Marhefka G, Elkashef A, Kahn R, Chiang CN, Vocci F, Cantilena L. Haigney MC, et al. Among authors: chiang cn. J Cardiovasc Electrophysiol. 2006 Jun;17(6):610-6. doi: 10.1111/j.1540-8167.2006.00421.x. J Cardiovasc Electrophysiol. 2006. PMID: 16836708 Clinical Trial.
Pharmacokinetic Interaction between Naloxone and Naltrexone Following Intranasal Administration to Healthy Subjects.
Krieter P, Chiang CN, Gyaw S, Skolnick P, Snyder R. Krieter P, et al. Among authors: chiang cn. Drug Metab Dispos. 2019 Jul;47(7):690-698. doi: 10.1124/dmd.118.085977. Epub 2019 Apr 16. Drug Metab Dispos. 2019. PMID: 30992306 Free PMC article. Clinical Trial.
Comparison of the Pharmacokinetic Properties of Naloxone Following the Use of FDA-Approved Intranasal and Intramuscular Devices Versus a Common Improvised Nasal Naloxone Device.
Krieter PA, Chiang CN, Gyaw S, McCann DJ. Krieter PA, et al. Among authors: chiang cn. J Clin Pharmacol. 2019 Aug;59(8):1078-1084. doi: 10.1002/jcph.1401. Epub 2019 Mar 12. J Clin Pharmacol. 2019. PMID: 30861160 Free PMC article. Clinical Trial.
Enhanced Intranasal Absorption of Naltrexone by Dodecyl Maltopyranoside: Implications for the Treatment of Opioid Overdose.
Krieter P, Gyaw S, Chiang CN, Crystal R, Skolnick P. Krieter P, et al. Among authors: chiang cn. J Clin Pharmacol. 2019 Jul;59(7):947-957. doi: 10.1002/jcph.1384. Epub 2019 Jan 30. J Clin Pharmacol. 2019. PMID: 30698833 Free PMC article.
Bulk Immiscibility at the Edge of the Nanoscale.
Chatzidakis M, Prabhudev S, Saidi P, Chiang CN, Hoyt JJ, Botton GA. Chatzidakis M, et al. Among authors: chiang cn. ACS Nano. 2017 Nov 28;11(11):10984-10991. doi: 10.1021/acsnano.7b04888. Epub 2017 Oct 26. ACS Nano. 2017. PMID: 29072899
26 results
Jump to page